ABSTRACT Background: Iron deficiency (ID) is a major cause of anemia, along with other nutritional, parasitic, and genetic factors. Accurate biomarkers are needed to estimate the relative contribution of ID to anemia. Soluble transferrin receptor (sTfR) is thought to be unaffected by inflammation. Objectives: The objectives were to determine the difference in sTfR and plasma ferritin (PF) concentrations among infants (6-23 mo of age), school-age children (6-8 y of age), and women (15-25 y of age) with and without inflammation and with and without Plasmodium falciparum infection and to assess the effect of adjusting sTfR and PF for inflammation or for P. falciparum infection on the estimated prevalence of ID. Design: The data were derived from a 14-mo prospective longitudinal survey on anemia, which was conducted in the Taabo area, south-central Côte d'Ivoire. Results: At baseline, sTfR concentration was significantly higher in infants and school-age children with either inflammation or P. falciparum infection than in control individuals without inflammation or without P. falciparum infection. Individuals with inflammation had significantly higher PF concentrations than did subjects without inflammation. Adjustments in sTfR concentrations for inflammation or P. falciparum infection in infants and school-age children resulted in significantly lower ID prevalence. Adjustment of PF for inflammation and Plasmodium infection resulted in a higher ID prevalence in infants and women. Conclusions: In Ivorian infants and school-age children, ID prevalence was considerably lower after adjustment of sTfR for inflammation. However, as the prevalence estimates for ID differed widely if based on sTfR or PF, caution is still needed when estimating ID prevalence in areas with a high prevalence of inflammation or malaria. This trialwas registered at controlled-trials.com as ISRCTN02181959.
INTRODUCTION
Anemia is a serious public health problem worldwide, with 1 of 4 people living with this condition (1) . The burden of anemia is highest in low-income countries, where up to 60% of children aged ,5 y and 45% of nonpregnant women are affected. In subSaharan Africa, anemia is multifactorial, including nutritional, parasitic, and genetic factors (2) (3) (4) (5) (6) (7) (8) . Iron deficiency (ID) 5 has long been accepted as the major etiologic agent of anemia, partly because hemoglobin has been widely used as a proxy to estimate the prevalence of ID. However, the first stages of ID do not affect hemoglobin synthesis, and some forms of anemia are not caused by ID (9) . To estimate the prevalence of ID and to quantify the differential contribution of ID to anemia, reliable biomarkers of iron status that have high sensitivity and specificity are needed (10) .
Ferritin, a protein ubiquitously expressed in the human body that is responsible for iron sequestration, is the classical biomarker used to estimate body storage iron (11) . In the absence of inflammation, the concentration of plasma ferritin (PF) reflects body iron reserves (12) . However, PF is also a positive acute phase protein, which renders its utilization as a marker of body iron stores challenging in individuals affected by inflammation (13) . The soluble form of the transferrin receptor (sTfR)-identified for the first time in serum in 1986 (14)-has become a widely used marker of ID in epidemiologic studies (15) (16) (17) . Of note, sTfR is expressed by iron-requiring cells (mainly erythroid precursors) and reflects cellular iron status and erythropoietic activity (18) . Previous studies have suggested that hemolytic and megaloblastic anemias, but not inflammation, might significantly alter sTfR concentrations (19) (20) (21) . However, 2 recent studies reported higher sTfR concentrations in individuals affected by subclinical inflammation (22, 23) .
Within the frame of a 14-mo prospective longitudinal study to assess the dynamics of anemia in 3 cohorts (infants, school-age children, and young women) in south-central Côte d'Ivoire, we found that, among other variables, cellular ID [defined as sTfR .8.5 mg/L (15, 24) ] was associated with increased odds of anemia (7, 25) . However, inflammation was also significantly associated with anemia in the 3 age groups studied, and ironstatus biomarkers and inflammatory biomarkers correlated significantly.
The objectives of this study were to expand on those initial observations to determine the relation between inflammation, Plasmodium falciparum infection, and sTfR and PF concentrations in different age groups at the baseline and at the end-of-study cross-sectional surveys and to assess the effect of adjusting sTfR and PF for inflammation or P. falciparum infection on the estimated prevalence of ID.
SUBJECTS AND METHODS

Study area, design, and population surveyed
The data for the current study stem from a 14-mo prospective longitudinal survey on the etiology of anemia, conducted in the Taabo health demographic surveillance system in south-central Côte d'Ivoire (7, (25) (26) (27) (28) . The baseline cross-sectional survey was conducted in April 2010, with repeated cross-sectional follow-up surveys every 3-4 mo. The end-of-study survey was carried out in June 2011 (Figure 1) .
At the beginning of the study, 732 participants were selected from the readily available database of the Taabo health demographic surveillance system. We focused on 3 population groups: 1) infants (6-23 mo of age; n = 237); 2) young schoolage children (6-8 y of age; n = 215); and 3) young women (15-25 y of age; n = 280) from Taabo Cit e (only small town of the area), Ahondo (village), and Katch enou (hamlet). Selected subjects were invited to participate in each of the cross-sectional surveys, even if they missed the baseline or any follow-up survey.
The study protocol was approved by the institutional research commissions of the Swiss Tropical and Public Health Institute (Basel, Switzerland; reference no. FK 96), the Eidgenössische Technische Hochschule Zurich (Zurich, Switzerland; reference no. EK 2009-N-19), and the ethics committees of Basel (EKBB; reference no. 252/09) and Côte d'Ivoire (reference no. 1086 MSHP/CNER). The investigators, the study physician, and laboratory technicians were covered by liability insurance (GNA Assurance). The purpose, procedures, potential risks, and benefits of the study were explained to village authorities and participating households. Written informed consent (or fingerprints of illiterate people) was obtained from study participants and parents/guardians of infants and school-age children. Participation was voluntary, and hence one could withdraw from the study at any time with no further obligations.
Procedures
At each survey, participants were registered, height and weight measured, a finger-prick blood sample taken, and the hemoglobin concentration measured by using a HemoCue 301 (HemoCue AB). Infection with P. falciparum was diagnosed by using a rapid diagnostic test (RDT; ICT ML01 malaria Pf kit; ICT Diagnostics). Plasmodium species-specific parasitemia was determined based on microscopic examination of Giemsa-stained thick and thin blood films. Soil-transmitted helminths and Schistosoma mansoni infections were diagnosed with the KatoKatz technique, whereas Schistosoma hematobium infection was determined with the urine filtration method (29, 30) . Venous blood samples (5-10 mL) were drawn from each participant at baseline and at the end-of-study survey directly into heparincoated tubes and stored in a cool-box containing ice, pending transfer to the laboratory in Taabo Cit e. Plasma was separated, portioned into aliquots, and stored at 2208C. The plasma samples were shipped on dry ice to Eidgenössische Technische Hochschule Zurich and subsequently transferred to Freiburg, Germany, for laboratory analyses of sTfR, PF, a 1 -acid glycoprotein (AGP), and C-reactive protein (CRP) by using a sandwich ELISA (31) . Each value represents the mean of an independent duplicate measurement. Inter-and intraassay CVs were ,9%.
At each cross-sectional survey, suspected clinical malaria cases (defined by a positive RDT plus tympanic temperature .388C) were treated with artesunate-amodiaquine (infants: 25 mg + 67.5 mg/d for 3 d; school-age children: 100 mg + 270 mg/ d for 3 d; women: 2 3 100 mg + 270 mg/d for 3 d; Maphar, Sanofi-Aventis). Nonpregnant subjects with soil-transmitted helminth infection (ie, Ascaris lumbricoides, hookworm, and Trichuris trichiura), as determined by at least one helminth egg on Kato-Katz thick smears, were given albendazole (400 mg for school-age children and women and 200 mg for infants; GlaxoSmithKline). School-age children and nonpregnant women with S. mansoni or S. hematobium, as determined by the presence of parasite eggs under a microscope, were treated with praziquantel (40 mg/kg; Bayer). Severely anemic subjects (ie, hemoglobin ,80 g/L, according to national guidelines of Côte d'Ivoire) with a positive RDT for malaria were treated with artesunateamodiaquine or were referred to the nearest health center if their RDT result was negative. These subjects were still eligible for enrollment.
Statistical analysis
Anemia was defined according to guidelines put forth by the WHO (9) . Because many women became pregnant during the 14 mo of our longitudinal monitoring, we did not exclude pregnant women but adapted the cutoff used for anemia, as proposed by the WHO. The thresholds used for defining abnormal values for the iron-status and inflammation biomarkers were as follows: sTfR .8.3 mg/L (cutoff usually used for measures done with the ELISA from Ramco Laboratories and another in-house ELISA) (22, 31) or .8.5 mg/L (cutoff used for minimizing the potential overestimation of ID prevalence and for comparing our results with previous findings from Côte d'Ivoire) (15, 24, 32) , PF ,12 mg/L (infants) or ,15 mg/L (school-age children and women) (9), CRP .5 mg/L, and AGP .1 g/L. Height-for-age z scores and weight-for-age z scores were calculated with the WHO AnthroPlus version 1.0.3. BMI was calculated for women as weight (kg)/size (in m) 2 . We defined 4 inflammatory states: 1) no inflammation (CRP #5 mg/L and AGP #1 g/L); 2) incubation (CRP .5 mg/L and AGP #1 g/L); 3) early convalescence (CRP .5 mg/L and AGP .1 g/L); and 4) late convalescence (CRP #5 mg/L and AGP .1 g/L) (22, 33) .
We used STATA version 10 (StataCorp) for the statistical analysis. Subjects who had values for all of the aforementioned variables at the baseline (n = 338) or end-of-study (n = 265) surveys with a tympanic temperature #388C and sTfR concentration $1 mg/L were considered for statistical analyses ( Figure 2 ). Spearman's rank correlation coefficients were calculated with natural log-transformed values of AGP, CRP, sTfR, PF, and P. falciparum parasitemia because the distribution of these variables was skewed, as defined by P values of skewness and Kurtosis tests for normality ,0.05. Means 6 SEs, medians 6 IQRs, and geometric means 6 SDs are reported. The sTfR/ ferritin index was calculated by dividing sTfR (mg/L) by log PF (mg/L), and the cutoff of ID was set to 5.3 (34) . We calculated the ratios of the geometric mean values of the iron indicator for the group with inflammation, or with Plasmodium infection, to the reference group without inflammation, or free of Plasmodium infection, respectively (33) . The correction factor (CF) was calculated as 1/ratio. We adjusted iron-status indicator concentrations by multiplying the measured individual values by their group-specific CF (22) . We used the Wilcoxon rank-sum and Kruskal-Wallis tests to assess for equality of sTfR concentrations between 2 or several groups, respectively. McNemar's chisquare statistics were used to compare the estimated prevalence based on nonadjusted values with prevalence calculated with adjusted values. Statistical significance was set to P , 0.05.
RESULTS
Biochemical characteristics of the study subjects
At baseline, similar numbers of males and females were enrolled in the infants and school-age children groups ( Table 1) . The prevalences of anemia, ID, and inflammation were highest among infants, irrespective of the choice of the biomarker of iron status (sTfR or PF) or inflammation (AGP or CRP), whereas school-age children had the highest prevalence of P. falciparum infection. Women had BMIs within the normal range (18.5-25) . Infants had median sTfR concentrations higher than the cutoff values used for defining ID (8.3 or 8.5 mg/L). Median PF concentrations were within the normal range in the 3 age groups.
The inflammatory biomarker AGP showed a significant positive correlation with both sTfR and PF in the 3 age groups and with P. falciparum parasitemia in infants and school-age children ( Table 2) . CRP showed a statistically significant positive correlation with sTfR in infants and school-age children and with PF concentration and P. falciparum parasitemia in each of the 3 cohorts. sTfR and hemoglobin showed significant negative correlations in all age groups, whereas PF and hemoglobin did not correlate significantly. There was a significant positive correlation between P. falciparum parasitemia and both sTfR and PF in infants and school-age children.
In multivariate logistic regression analyses, we found no significant association between sTfR and CRP in any of the 3 age groups investigated (see Supplemental Tables S1 and S2 under "Supplemental data" in the online issue). At baseline, we found a significant positive association between AGP and sTFR in infants and school-age children after adjustment for age, sex, hemoglobin, P. falciparum parasitemia, and PF.
sTfR and PF ratios in infants, school-age children, and women with or without inflammation and with or without P. falciparum infection At baseline, the respective percentage of subjects within the incubation and early and late convalescence stages were 1%, 36%, and 21% in infants; 3%, 18%, and 18% in school-age children; and 9%, 4%, and 7% in women, respectively ( Table 3) . sTfR and PF showed distinct profiles during incubation, early convalescence, and late convalescence (Table 3 and Table 4 ). Whereas the highest concentrations of sTfR were measured at the late stage of convalescence for school-age children and women, the PF concentration was highest in subjects at early convalescence. At baseline, infants, school-age children, and women with elevated CRP and AGP (early convalescence) had significantly higher sTfR and PF concentrations than did control individuals without inflammation, although the association was not statistically significance for sTfR in women, presumably because of the low number of women with inflammation (Table  3) . No significant difference in the sTfR/ferritin index was found between participants with inflammation (incubation or early or late convalescence) and control individuals, except for schoolage children in late convalescence stage. We found similar ratios for sTfR and PF at the end-of-study survey, although for infants and women they were nonsignificant (Table 4 ). Infants and school-age children with inflammation (defined as CRP .5 mg/ L or AGP .1 g/L) or with P. falciparum infection had significantly higher sTfR concentrations than did the control individuals without inflammation, whereas the PF concentration was not affected by inflammation in the absence of parasitemia in these 2 age groups ( Table 5 ). The mean age of infants with inflammation was higher than the mean age of infants without inflammation (16.1 6 0.6 mo compared with 13.7 6 0.9 mo; Wilcoxon's rank-sum test, P = 0.028). Infants with P. falciparum infection (with or without inflammation) were significantly older than infants free of infection (16.5 6 0.7 mo compared with 14.1 6 0.7 mo; Wilcoxon's rank-sum test, P = 0.029). No significant difference was found in school-age children and women.
Adjustment of sTfR and PF concentrations and of the sTfR/ferritin index for inflammation or P. falciparum infection At baseline, correction of sTfR for inflammation only or for inflammation and P. falciparum infection in infants significantly decreased the estimated prevalence of ID from 74% to 60% and 54%, respectively, whereas correction of PF for inflammation significantly increased ID prevalence from 15% to 23% (Table  6 ). In school-age children, adjustment of sTfR or the sTfR/ferritin index for inflammation or P. falciparum infection significantly decreased the estimated prevalence of ID, whereas adjustment of PF for inflammation had no effect. In women, correction of sTfR or PF for P. falciparum infection and inflammation significantly decreased or, respectively, increased the prevalence of ID. The prevalence of ID in infants and school-age children was lower at the end-of-study survey than at Geometric mean ratio that compares the iron biomarker concentration at each inflammatory stage with that of the control group.
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Estimated from the ratios of the geometric means as explained in references 22 and 33. baseline. In these 2 cohorts, correction of sTfR for inflammation had similar effects at the end-of-study survey than at baseline ( Table 7) .
DISCUSSION
Data from this 14-mo prospective longitudinal monitoring study in 3 different age groups in a primarily rural part of Côte d'Ivoire showed that both sTfR and PF concentrations can be influenced by inflammation and P. falciparum infection status. Although infants and school-age children with inflammation but free of P. falciparum infection had significantly higher sTfR concentrations than did their counterparts without inflammation, inflammation without parasitemia did not significantly alter PF concentrations. Importantly, we showed that adjustment of baseline sTfR values for inflammation resulted in a considerable decrease in the estimated prevalence of ID from 74% to 59% in infants and from 42% to 26% in school-age children. Our findings are important because sTfR has previously been considered not to be affected by inflammation, and sTfR is increasingly being used to measure the prevalence of ID in settings where inflammatory disorders are widespread and where malaria is endemic (15) (16) (17) 35) .
Our study had several limitations. First, the sample size was relatively small, and hence did not allow comparison of CFs for the 3 inflammation groups between subjects with and without P. falciparum infection. Furthermore, the overall low prevalence of inflammation in women (w20%) might have blunted a significant association between inflammation and iron-status biomarkers in this age group. Second, the mean age of infants with inflammation or with P. falciparum infection was slightly higher than the mean age of their counterparts without inflammation or without Plasmodium infection. However, because the sTfR concentration decreased with the age of the infants (overall Spearman's r: 20.24, P = 0.001), it is not conceivable that the significantly higher sTfR concentrations observed in infants with inflammation or P. falciparum infection were explained by the higher age in this group. Third, considering that our study did not specifically investigate the causes of inflammation due to factors other than infection with P. falciparum we cannot exclude that other infectious diseases (eg, HIV/AIDS and diarrhea) trigger sTfR productions in response to hemolysis or ineffective erythropoiesis. A general limitation encountered in field studies in resource-constrained settings is the unfeasibility of collecting bone marrow aspirate, which in turn prevents a comparison of the specificity and sensitivity of sTfR and PF in estimating ID prevalence with this unambiguous and objective measure. Another limitation found in most studies that use AGP as inflammatory marker is the lack of an objective cutoff defining inflammation. As an example, in this study the prevalence of ID in infants significantly increased from 35% (95% CI: 26%, 45%) to 62% (95% CI: 51%, 71%) based on sTfR concentrations adjusted for inflammation defined as AGP .0.7 or .1.1 g/L, respectively. Considering the inflammatory stages used by Thurnham et al (33) and others (22) , sTfR and PF showed distinct dynamics in response to inflammation. The relative number of infants in the different phases of convalescence was similar to what has been observed in Kenya and Pakistan in subjects with similar age ranges (22, 36) . The profiles of sTfR and PF during the different stages of convalescence suggest that they are differentially regulated by inflammation. Whereas PF reacts promptly and markedly to inflammation, the concentrations of sTfR are highest during the early and late stages of convalescence. On the one hand, the sTfR concentration might increase relatively to TfR expression in erythroid progenitor cells, in response to the lack of iron for erythropoiesis. The lack of plasma iron results from an increase in the hepcidin concentration, which prevents ironexported either from macrophages or from enterocytes-from entering the plasma (37) . On the other hand, TfR transcription, and hence sTfR concentration, might be stimulated in macrophages in response to increased hypoxia-inducible factor-1 translation because of infection and/or inflammation (38, 39) . Previous studies have shown that hypoxia-inducible factor-1 binds to the promoter site of the TfR gene, which might increase TfR transcription (40) . The regulation of sTfR, and of CRP and AGP, by inflammatory cytokines is not well characterized; thus, new research is needed to deepen the understanding of sTfR regulation in response to inflammation. The observation that inflammation status influenced sTfR concentrations slightly less after 14 mo of selective medical interventions, coupled with a significantly lower prevalence of anemia in the infants and school-age children groups, suggests that ID might also contribute to the difference in sTfR concentration between individuals with and without subclinical inflammation.
The observation that PF and inflammatory biomarkers was significantly positively correlated in the 3 cohorts studied here confirms the widely acknowledged poor sensitivity of this marker to detect ID in populations with a high prevalence of infections or inflammations (41) . Furthermore, our data confirm the results of 2 recent studies conducted among Kenyan and Zimbabwean preschool-age children, which reported a significant association between inflammation status and sTfR concentration (22, 23) . The observation that infants and school-age children with Plasmodium infection have significantly higher concentrations of sTfR also confirms previous findings (19, 42) and suggests that, in this age group, malaria-induced hemolysis is coupled with an increased erythropoietic rate. The lack of a significant difference in sTfR concentrations between women with and without inflammation might be explained by the relatively small sample size in this age group. Yet, our findings might indicate that the consequence of inflammation differs across age classes. Of note, 2 infants (7 and 10 mo of age) with $5000 Plasmodium parasites/mL blood and tympanic temperature .388C (excluded for the analyses presented here) had sTfR concentrations ,1 mg/L, which indicates that clinical malaria may decrease sTfR concentrations (42) . In relation to a correction for the elevated PF, the current study indicates that the use of the CFs obtained in a previous metaanalysis (33) provided similar results (Table 6 ). However, the use of CFs per se might be questionable, because we found considerable differences between the estimated prevalence of ID based on sTfR or PF concentrations, either uncorrected or corrected for inflammation. Other studies have found a large difference in ID prevalence between estimates based on sTfR and PF in infants and school-age children (6, 15, 35) . In relation to elevated sTfR/ferritin indexes, because our results indicate that both ID and inflammation are associated with higher sTfR concentrations, the utility of this marker to distinguish subjects with anemia of inflammation from subjects with anemia of inflammation and ID might be challenged (44, 45) . Indeed, it is likely that the sTfR/ferritin index overlaps considerably between individuals with anemia of inflammation only and those with anemia of inflammation and ID anemia; hence, this would prevent the use of this index to distinguish between both types of anemia.
In conclusion, our findings indicate that the sTfR concentration is higher in infants and school-age children with subclinical inflammation or with P. falciparum infection. Moreover, ID prevalence is significantly lower when CFs based on sTfR concentrations in otherwise comparable subjects with no inflammation are applied. As reported elsewhere, the PF concentration was significantly higher in infants and school-age children affected by subclinical inflammation, and ID prevalence increased when CFs were applied. However, because ID prevalence estimated based on sTfR or PF (with or without corrections) showed considerable differences, caution is still needed when measuring iron status in areas of widespread inflammatory disorders or high endemicity of malaria. Our observations should be considered when setting up refined guidelines about the prevention and control of ID in malariaendemic countries (46) . Indeed, if screening for ID is maintained as a prerequisite to iron supplementation (47), accurate and robust markers must be used; therefore, caution is currently indicated if sTfR or PF is being used.
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